GOP Representative Lawler Labels Marijuana a 'Gateway Drug' While Opposing Trump's Rescheduling Proposal
Lawmaker's Concerns: Rep. Mike Lawler (R-N.Y.) expressed concerns about President Trump's potential plan to reschedule marijuana, labeling it a "gateway drug" and highlighting the increased THC levels in modern cannabis compared to decades ago.
Trump's Executive Order: President Trump confirmed he is considering an Executive Order to move marijuana from Schedule I to Schedule III under the Controlled Substances Act.
Market Reaction: Following the news, cannabis multi-state operators saw significant gains in trading, with companies like Ascend Wellness and Curaleaf Holdings among those benefiting.
Investment Insights: The article mentions various cannabis ETFs and provides insights into the performance of companies like Curaleaf and Trulieve, suggesting potential investment opportunities amidst market volatility.
About the author









